Literature DB >> 27911247

Correlation of mortality with lesion level in patients with myelomeningocele: a population-based study.

Joel Haakon Borgstedt-Bakke1, Morten Fenger-Grøn2, Mikkel Mylius Rasmussen1.   

Abstract

OBJECTIVE The aim of this study was to assess myelomeningocele mortality, correlate these findings to lesion level, and investigate mortality evolution. METHODS From the population-based western Denmark myelomeningocele database, the authors extracted the records of 187 patients born between January 1, 1970, and July 1, 2015. Patients were categorized according to their most rostral lesion level into cervical, thoracic, lumbar, or sacral groups. Furthermore, patients were categorized based on their birth dates (1970-1979, 1980-1989, and 1990-2015). Mortality data was extrapolated from the university hospital's electronic charts, which are based on the Danish Civil Registration System, and compared according to mortality, lesion level, and date of birth. Data were also extracted from nationwide Danish registers. Additionally, the authors divided the patients according to date of birth before or after the advent of prenatal detection (2004), and compared mortality rates of these two groups. RESULTS A thoracic lesion level was associated with a significantly higher mortality rate (p = 0.01). Two patients had a cervical lesion and were alive at the end of follow-up. The mortality rate decreased over time, although not significantly for the subsequent time periods. Prenatal detection did not affect mortality. CONCLUSIONS The presented data suggest increased mortality with ascending lesion level in patients with myelomeningocele, except for patients with cervical lesions. The mortality rate improved over time, suggesting that modern treatment modalities improve survival in patients with myelomeningocele.

Entities:  

Keywords:  CI = confidence interval; HR = hazard ratio; age group; congenital; mortality; myelomeningocele; sex; spina bifida; spine

Mesh:

Year:  2016        PMID: 27911247     DOI: 10.3171/2016.8.PEDS1654

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  7 in total

1.  Correlation Between Neurologic Impairment Grade and Ambulation Status in the Adult Spina Bifida Population.

Authors:  Anne C Tita; John R Frampton; Christian Roehmer; Sara E Izzo; Amy J Houtrow; Brad E Dicianno
Journal:  Am J Phys Med Rehabil       Date:  2019-12       Impact factor: 2.159

2.  Opportunities for augmentation cystoplasty revision without additional bowel harvest: "Hourglass" deformity or non-detubularized augment.

Authors:  Joseph J Pariser; Sean P Elliott
Journal:  Can Urol Assoc J       Date:  2018-10-15       Impact factor: 1.862

3.  Neonatal and infant mortality associated with spina bifida: A systematic review and meta-analysis.

Authors:  Peter Ho; Maria A Quigley; Dharamveer Tatwavedi; Carl Britto; Jennifer J Kurinczuk
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

4.  Factors Associated with Early Neonatal and First-Year Mortality in Infants with Myelomeningocele in California from 2006 to 2011.

Authors:  Vijaya Kancherla; Chen Ma; Gerald Grant; Henry C Lee; Susan R Hintz; Suzan L Carmichael
Journal:  Am J Perinatol       Date:  2020-05-30       Impact factor: 1.862

5.  A Case of Fatal Pulmonary Hypoplasia with Congenital Diaphragmatic Hernia, Thoracic Myelomeningocele, and Thoracic Dysplasia.

Authors:  Ai Ito; Hideshi Fujinaga; Sachiko Matsui; Kumiko Tago; Yuka Iwasaki; Shuhei Fujino; Junko Nagasawa; Shoichiro Amari; Masao Kaneshige; Yuka Wada; Shigehiro Takahashi; Keiko Tsukamoto; Osamu Miyazaki; Takako Yoshioka; Akira Ishiguro; Yushi Ito
Journal:  AJP Rep       Date:  2017-12-29

Review 6.  Spinal Cord Injury in Myelomeningocele: Prospects for Therapy.

Authors:  Karolina Janik; Meredith A Manire; George M Smith; Barbara Krynska
Journal:  Front Cell Neurosci       Date:  2020-06-30       Impact factor: 5.505

7.  Surgical Outcomes after Myelomeningocele Repair in Lusaka, Zambia.

Authors:  Rebecca A Reynolds; Arnold Bhebhe; Roxanna M Garcia; Heidi Chen; Christopher M Bonfield; Sandi Lam; Kachinga Sichizya; Chevis Shannon
Journal:  World Neurosurg       Date:  2020-10-19       Impact factor: 2.104

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.